US Patent Issued to APELIOTUS TECHNOLOGIES, MASSACHUSETTS EYE AND EAR INFIRMARY on May 26 for "Functional biomarkers for statin therapy in age-related macular degeneration (AMD)" (Pennsylvania, Massachusetts Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,640,239, issued on May 26, was assigned to APELIOTUS TECHNOLOGIES INC. (Philadelphia) and MASSACHUSETTS EYE AND EAR INFIRMARY (Boston).

"Functional biomarkers for statin therapy in age-related macular degeneration (AMD)" was invented by John G. Edwards (Philadelphia), Joan W. Miller (Winchester, Mass.) and Demetrios Vavvas (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of using visual functions such as dark adaptation, low luminance visual acuity, low luminance deficit, contrast sensitivity and scotopic sensitivity as functional biomarkers for statin therapy in AMD. These biomarkers can be used, for example, to support clinical trials of ...